FDA Inspection 1250007 — Y-maAbs Therapeutics, Inc.
The FDA completed an inspection of Y-maAbs Therapeutics, Inc. on Aug 23, 2024 in New York, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 23, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- New York, NY (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)